De Lorenzo, Rebecca
Mazza, Mario G.
Sciorati, Clara
Leone, Roberto
Scavello, Francesco
Palladini, Mariagrazia
Merolla, Aurora
Ciceri, Fabio
Bottazzi, Barbara
Garlanda, Cecilia
Benedetti, Francesco
Rovere-Querini, Patrizia
Manfredi, Angelo A.
Funding for this research was provided by:
Philanthropic donation by Dolce & Gabbana fashion
Ministero della Salute (GR-2021-12374872-1, COVID-2020-12371640, COVID-2020–12371617, COVID-2020–12371617, COVID-2020–12371617, COVID-2020–12371617)
NextGeneration EU-MUR PNRR (PE00000007)
Article History
Accepted: 10 March 2024
First Online: 24 April 2024
Declarations
:
: This work was supported by a philanthropic donation by Dolce & Gabbana fashion house (to BB and CG), by the Italian Ministry of Health (grant GR-2021-12374872-1 to MGM), by the Italian Ministry of Health for COVID-19 (grants COVID-2020-12371640 to CG and COVID-2020–12371617 to FC, FB, PR-Q, and AAM), by EU funding within the NextGenerationEU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases (Project no. PE00000007, INF-ACT, to CG), and by a COVID-19 program project grant from the IRCCS San Raffaele Hospital (to FC, FB, PR-Q, and AAM).
: The authors declare no competing interests.
: The COVID-BioB and the PT-COVID study protocols, compliant with the 1964 Declaration of Helsinki and its later amendments, were approved by the Hospital Ethics Committee.
: All patients signed informed consent.
: Not applicable.
: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
: Not applicable.
: MGM, RDL, and CS designed the study. MGM, RDL, MP, AM, and FB examined the patients and collected clinical and laboratory data. CS, RL, FS, BB, and CG analyzed the biomarkers. MGM and RDL performed the statistical analyses and wrote the first draft. All authors have read and approved the final submitted manuscript and agree to be accountable for the work.